STRO
$4.72
Sutro Biopharma
$.26
5.83%
STRO
Earnings Whisper ®
N/A
2nd Quarter June 2023
Consensus:  ($0.72)
Revenue:  $11.81 Mil
Monday
Aug 14
4:30 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when STRO reports earnings?
Beat
Meet
Miss

Where is STRO's stock price going from here?
Up
Flat
Down
Stock chart of STRO
Analysts
Summary of analysts' recommendations for STRO
Score
Grade
Pivots
Resistance
$5.15
$4.94
$4.83

$4.62

Support
$4.51
$4.30
$4.19
Tweet
Growth
Description
Sutro Biopharma Inc. develops and manufactures pharmaceutical products. The Company provides antibody drug conjugate and multi-specific antibody-based therapeutics for cancer therapy. Its product pipeline consists of STRO-001 and STRO-002 which are in clinical stage. Sutro Biopharma Inc. is based in South San Francisco, California.